Which circumstance bypasses pharmacist prospective DUR?

Study for the FIPA 2 Exam 3. Hone your skills with flashcards and multiple choice questions, each question with hints and explanations. Prepare for your exam confidently!

Multiple Choice

Which circumstance bypasses pharmacist prospective DUR?

Explanation:
The main idea here is that a pharmacist-prospective DUR is meant to catch issues before dispensing, but in true emergencies where delaying therapy could harm the patient, that review can be bypassed so treatment isn’t delayed. Why the stated scenario is the best fit: if the prescriber controls the ordering, preparing, and administering, and a delay would harm the patient, there isn’t time for the pharmacist to perform a DUR check. The patient needs immediate action, so the process relies on the prescriber’s judgment and the care team takes charge directly. This is exactly the kind of urgent situation that overrides the usual pharmacist-led screening. The other possibilities don’t capture this urgent bypass condition. They still imply ongoing pharmacist control or don’t reflect a situation where delaying therapy would harm the patient, so they don’t illustrate the exception that allows bypassing the prospective DUR.

The main idea here is that a pharmacist-prospective DUR is meant to catch issues before dispensing, but in true emergencies where delaying therapy could harm the patient, that review can be bypassed so treatment isn’t delayed.

Why the stated scenario is the best fit: if the prescriber controls the ordering, preparing, and administering, and a delay would harm the patient, there isn’t time for the pharmacist to perform a DUR check. The patient needs immediate action, so the process relies on the prescriber’s judgment and the care team takes charge directly. This is exactly the kind of urgent situation that overrides the usual pharmacist-led screening.

The other possibilities don’t capture this urgent bypass condition. They still imply ongoing pharmacist control or don’t reflect a situation where delaying therapy would harm the patient, so they don’t illustrate the exception that allows bypassing the prospective DUR.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy